C. K. CHU

2.6k citations

61 papers · 2.2k indexed · h-index 21

Impact in

Virology top 1%
- HIV Research and Treatment
Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Virology 22
- HIV Research and Treatment 22
Infectious Diseases 42
- HIV/AIDS drug development and treatment 41
- HIV/AIDS Research and Interventions 6

Co-authors: Raymond F. Schinazi (26 shared papers)Deborah Cannon (4 shared papers)Dennis C. Liotta (3 shared papers)A. McMillan (2 shared papers)Lak Shin Jeong (5 shared papers)Joseph Warren Beach (5 shared papers)Patrick Van Roey (5 shared papers)S. Balakrishna Pai (4 shared papers)
Journals: Antimicrobial Agents and Chemotherapy (9 papers)Antiviral chemistry & chemotherapy (6 papers)The Journal of Organic Chemistry (4 papers)Journal of Medicinal Chemistry (3 papers)Annals of the New York Academy of Sciences (3 papers)
Partner nations: United States Taiwan Netherlands

In The Last Decade

C. K. CHU

60 papers receiving 2.1k citations

Peers

Countries citing papers authored by C. K. CHU

Since Specialization

Citations

This map shows the geographic impact of C. K. CHU's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. K. CHU with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. K. CHU more than expected).

Fields of papers citing papers by C. K. CHU

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. K. CHU. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. K. CHU. The network helps show where C. K. CHU may publish in the future.

Co-authors

The 25 scholars most cited alongside C. K. CHU, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. K. CHU Line = papers co-authored together C. K. CHU links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides Antimicrobial Agents and Chemotherapy ·Raymond F. Schinazi, Robert M. Lloyd, M. Hong Nguyen, Deborah Cannon, A. McMillan, N Ilksoy, C. K. CHU, Dennis C. Liotta, Holly Bazmi, John W. Mellors	1993	326
2	Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes Antimicrobial Agents and Chemotherapy ·Raymond F. Schinazi, C. K. CHU, A Peck, A. McMillan, R Mathis, Deborah Cannon, Lak Shin Jeong, Joseph Warren Beach, Woo‐Baeg Choi, Suresh Yeola	1992	231
3	Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication. Journal of Biological Chemistry ·C.N. Chang, Shin-Lian Doong, Junhu Zhou, Joseph Warren Beach, Lak Shin Jeong, C. K. CHU, Ching-hwa Tsai, Ying‐Chih Cheng, Dennis C. Liotta, Raymond F. Schinazi	1992	198
4	Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus Antimicrobial Agents and Chemotherapy ·C. K. CHU, Tianwei Ma, Kirupa Shanmuganathan, C Wang, Yufei Xiang, S. Balakrishna Pai, G.-Q. Yao, J P Sommadossi, Ying‐Chih Cheng	1995	192
5	Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil Antimicrobial Agents and Chemotherapy ·S. Balakrishna Pai, S H Liu, Y.‐L. Zhu, C. K. CHU, Y C Cheng	1996	118
6	Antiviral Activity of Clevudine [L–Fmau, (1–(2–Fluoro–5–Methyl–β, L–Arabinofuranosyl) Uracil)] Against Woodchuck Hepatitis Virus Replication and Gene Expression in Chronically Infected Woodchucks ( Marmota Monax ) Hepatology ·Simon F. Peek, Paul J. Côté, James R. Jacob, Ilia Toshkov, William E. Hornbuckle, B. H. Baldwin, Frances V. Wells, C. K. CHU, J. L. Gerin, Bud C. Tennant, Brent E. Korba	2001	106
7	General syntheses of 2',3'-dideoxynucleosides and 2',3'-didehydro-2',3'-dideoxynucleosides The Journal of Organic Chemistry ·C. K. CHU, V. S. Bhadti, Bogdan Doboszewski, ZM Gu, Yoshiyuki Kosugi, K. C. Pullaiah, Patrick Van Roey	1989	104
8	Correlation between preferred sugar ring conformation and activity of nucleoside analogues against human immunodeficiency virus. Proceedings of the National Academy of Sciences ·Patrick Van Roey, Jeffrey M. Salerno, C. K. CHU, Raymond F. Schinazi	1989	81
9	Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro Antimicrobial Agents and Chemotherapy ·R. F. SCHINAZI, Gilles Gosselin, Achraf Al Faraj, Brent E. Korba, Dennis C. Liotta, C. K. CHU, Christophe Mathé, Jean‐Louis Imbach, J P Sommadossi	1994	80
10	1,3-Dioxolanylpurine nucleosides (2R,4R) and (2R,4S) with selective anti-HIV-1 activity in human lymphocytes Journal of Medicinal Chemistry ·H. O. KIM, Raymond F. Schinazi, Satyanarayana Nampalli, Kirupa Shanmuganathan, Deborah Cannon, Antônio J. Alves, Lak Shin Jeong, Joseph Warren Beach, C. K. CHU	1993	78
11	Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine Journal of Medicinal Chemistry ·C. K. CHU, V. S. Bhadti, K J Doshi, Joseph T. Etse, James M. Gallo, F. Douglas Boudinot, R. F. SCHINAZI	1990	73
12	Determination of the Anomeric Configuration of C-Nucleosides by¹H and¹³C NMR Spectroscopy Nucleosides and Nucleotides ·C. K. CHU, F. M. El-kabbani, B. Blackburn Thompson	1984	50
13	A Stereochemical Rationale for the Activity of Anti-HIV Nucleosides Antiviral chemistry & chemotherapy ·Ethan Will Taylor, Patrick Van Roey, Raymond F. Schinazi, C. K. CHU	1990	47
14	Nucleosides. 100. General synthesis of pyrimidine C-5 nucleosides related to pseudouridine. Synthesis of 5-(.beta.-D-ribofuranosyl)isocytosine (pseudoisocytidine), 5-(.beta.-D-ribofuranosyl)-2-thiouracil (2-thiopseudouridine), and 5-(.beta.-D-ribofuranosyl)uracil (pseudouridine) The Journal of Organic Chemistry ·C. K. CHU, Iris Wempen, K. A. WATANABE, Jack J. Fox	1976	45
15	Phosphorylation of 3'-azido-2',3'-dideoxyuridine and preferential inhibition of human and simian immunodeficiency virus reverse transcriptases by its 5'-triphosphate Antimicrobial Agents and Chemotherapy ·B. Eriksson, C. K. CHU, Raymond F. Schinazi	1989	44
16	Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice. Drug Metabolism and Disposition ·K J Doshi, James M. Gallo, F. Douglas Boudinot, Raymond F. Schinazi, C. K. CHU	1989	37
17	Pharmacokinetics of (-)-2'-3'-dideoxy-3'-thiacytidine in woodchucks Antimicrobial Agents and Chemotherapy ·Prabhu Rajagopalan, F. Douglas Boudinot, C. K. CHU, Bud C. Tennant, B. H. Baldwin, Raymond F. Schinazi	1996	31
18	Antiviral activity of cyclopentenyl nucleosides against orthopox viruses (Smallpox, monkeypox and cowpox) Bioorganic & Medicinal Chemistry Letters ·C. K. CHU, Yun Jin, Robert O. Baker, John W. Huggins	2003	30
19	Nucleosides. CIX. 2′‐Deoxy‐ψ‐isocytidine, 2 ‐deoxy‐ψ‐uridine, and 2′‐deoxy‐l‐methyl‐ψ‐uridine. Isosteres of deoxycytidine, deoxyuridine and thymidine Journal of Heterocyclic Chemistry ·C. K. CHU, U. REICHMAN, Kyoichi A. Watanabe, Jack J. Fox	1977	23
20	Activity and Mechanism of Action of HDVD, a Novel Pyrimidine Nucleoside Derivative with High Levels of Selectivity and Potency against Gammaherpesviruses Journal of Virology ·N. Coen, Uma S. Singh, V. Vuyyuru, Joost J. van den Oord, Jan Balzarini, Sophie Duraffour, Robert Snoeck, Ying‐Chih Cheng, C. K. CHU, Graciela Andreï	2013	21

About C. K. CHU

C. K. CHU is a scholar working on Virology, Infectious Diseases, Organic Chemistry, Epidemiology and Hepatology, having authored 61 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (41 papers), HIV Research and Treatment (22 papers), Biochemical and Molecular Research (11 papers), Hepatitis B Virus Studies (10 papers), Cytomegalovirus and herpesvirus research (9 papers), Synthesis and Characterization of Heterocyclic Compounds (9 papers), HIV/AIDS Research and Interventions (6 papers) and Carbohydrate Chemistry and Synthesis (5 papers). The work is most often cited by research in Virology (769 citations), Infectious Diseases (1.4k citations), Hepatology (380 citations), Epidemiology (792 citations) and Organic Chemistry (582 citations). C. K. CHU has collaborated with scholars based in United States, Taiwan and Netherlands. Frequent co-authors include Raymond F. Schinazi, Deborah Cannon, Dennis C. Liotta, A. McMillan, Lak Shin Jeong, Joseph Warren Beach, Patrick Van Roey, S. Balakrishna Pai, Ying‐Chih Cheng and F. Douglas Boudinot. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Antiviral chemistry & chemotherapy, The Journal of Organic Chemistry, Journal of Medicinal Chemistry and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact